Riccardo Colombo and colleagues found that by selectively inhibiting Mps1, a crucial SAC component primarily responsible for chromosome alignment and the kinetochore–microtubule interaction, effectively inhibited tumor growth in various preclinical cancer models [19]. This evidence concerns the gene ADCY10 and neoplasm.